Denise D. Correa

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

32h-index4.6kcitations100works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(58), Brain Metastases and Treatment(42), Cancer-related cognitive impairment studies(38), CNS Lymphoma Diagnosis and Treatment(24), Functional Brain Connectivity Studies(6)

Publications99 total

T51. IDENTIFYING KEY CELLULAR ALTERATIONS IN AUTISM SPECTRUM DISORDER: INSIGHTS FROM A DYSTROPHINOPATHY MODEL
European Neuropsychopharmacology·2025
Multicenter randomized phase II study of R-MPV-A chemoimmunotherapy with or without low-dose whole-brain radiotherapy for newly-diagnosed primary CNS lymphoma
Neuro-Oncology·2025· 3 citedOpen Access
Neurocognitive functioning in patients with Cancer involving the central nervous system
Journal of Clinical and Experimental Neuropsychology·2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis
JAMA Oncology·2025· 6 citedOpen Access
Anxiety and depression in patients with histiocytic neoplasms and their associated clinical features
Blood Advances·2024Open Access
Pilot Study of Longitudinal Geriatric Assessment and Neurocognitive Evaluation in CAR T-Cell Therapy for Older Patients with Relapsed Refractory, Large B-Cell Lymphoma
Blood·2023Open Access
Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation
Cancers·2023· 3 citedOpen Access
Neuroimaging and Neurocognitive Outcomes in Older Patients with Multiple Myeloma Treated with Chemotherapy and Autologous Stem Cell Transplantation
Research Square (Research Square)·2023· 1 citedOpen Access
Supplementary Data 1 - 7 from Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
2023Open Access
Data from Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
2023Open Access
Supplementary Data 1 - 7 from Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
2023Open Access
Data from Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
2023Open Access
Longitudinal Evaluation of Brain Plasticity in Low-Grade Gliomas: fMRI and Graph-Theory Provide Insights on Language Reorganization
Cancers·2023· 10 citedOpen Access
SPCR-02 NEUROCOGNITIVE FUNCTION IN PATIENTS WITH LEPTOMENINGEAL METASTASIS TREATED WITH PROTON CRANIOSPINAL IRRADIATION
Neuro-Oncology Advances·2022· 1 citedOpen Access
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis
Journal of Clinical Oncology·2022· 130 citedOpen Access
Phase II randomized study comparing proton craniospinal irradiation with photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis.
Journal of Clinical Oncology·2022· 3 cited
Variabilidade da composição nutricional de coprodutos de etanol de milho do Brasil para suínos
Research Society and Development·2021· 5 citedOpen Access
Altered regional homogeneity in patients with ovarian cancer treated with chemotherapy: a resting state fMRI study
Brain Imaging and Behavior·2021· 8 citedOpen Access
Narrative review of primary central nervous system lymphoma: treatment-related neurotoxicity
Annals of Lymphoma·2021· 1 citedOpen Access
Neurocognitive functions in primary CNS lymphoma
Neuro-Oncology·2021· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lisa M. DeAngelis(24), Lauren E. Abrey(17), Antonio Omuro(9), Raymond E. Baser(8), Howard T. Thaler(8), Sasan Karimi(7), Norman Relkin(7), Philip H. Gutin(7), Maria Kryza‐Lacombe(7), Joachim Yahalom(5), Elena Pentsova(5), Cameron Brennan(5), Christian Grommes(4), Katherine S. Panageas(4), Joy Hirsch(4), Maximilian I. Ruge(4), Jonathan D. Victor(4), Viviane Tabar(4), Irene Orlow(4), James C. Root(4)